Arizona State Retirement System’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-30,510
| Closed | -$2.2M | – | 2089 |
|
|
2025
Q4 | $2.2M | Sell |
30,510
-1,392
| -4% | -$89.9K | 0.01% | 724 |
|
|
2025
Q3 | $1.39M | Buy |
31,902
+5,623
| +21% | +$227K | 0.01% | 973 |
|
|
2025
Q2 | $746K | Buy |
26,279
+2,314
| +10% | +$69K | ﹤0.01% | 1262 |
|
|
2025
Q1 | $707K | Sell |
23,965
-1,772
| -7% | -$55.2K | ﹤0.01% | 1242 |
|
|
2024
Q4 | $748K | Buy |
25,737
+2,805
| +12% | +$117K | ﹤0.01% | 1277 |
|
|
2024
Q3 | $1.05M | Buy |
22,932
+2,967
| +15% | +$129K | 0.01% | 1069 |
|
|
2024
Q2 | $816K | Buy |
19,965
+405
| +2% | +$11.6K | 0.01% | 1148 |
|
|
2024
Q1 | $499K | Buy |
19,560
+2,989
| +18% | +$46.8K | ﹤0.01% | 1449 |
|
|
2023
Q4 | $150K | Buy |
16,571
+439
| +3% | +$2.94K | ﹤0.01% | 2033 |
|
|
2023
Q3 | $103K | Sell |
16,132
-773
| -5% | -$6.66K | ﹤0.01% | 2073 |
|
|
2023
Q2 | $187K | Buy |
16,905
+1,499
| +10% | +$18.8K | ﹤0.01% | 1979 |
|
|
2023
Q1 | $236K | Buy |
15,406
+4,375
| +40% | +$96.3K | ﹤0.01% | 1836 |
|
|
2022
Q4 | $245K | Buy |
11,031
+889
| +9% | +$13.3K | ﹤0.01% | 1796 |
|
|
2022
Q3 | $166K | Buy |
+10,142
| New | +$194K | ﹤0.01% | 1955 |
|
|
2022
Q1 | – | Sell |
-9,190
| Closed | -$218K | – | 2256 |
|
|
2021
Q4 | $218K | Sell |
9,190
-129
| -1% | -$3.08K | ﹤0.01% | 2041 |
|
|
2021
Q3 | $230K | Buy |
+9,319
| New | +$203K | ﹤0.01% | 2002 |
|
Other funds holding RNAM
Arizona State Retirement System's RNAM Position: Q1 2026 in Review
Arizona State Retirement System sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 30,510 shares — an estimated $2.2M sold.
Arizona State Retirement System first reported a position in RNAM in Q3 2021 and held it in 16 quarters. The position peaked at $2.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Arizona State Retirement System reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Arizona State Retirement System sold 30,510 Avidity Biosciences shares in Q1 2026, an estimated $2.2M.
- Arizona State Retirement System first reported a position in Avidity Biosciences in Q3 2021 and held it in 16 quarters.
- Arizona State Retirement System's Avidity Biosciences position peaked at $2.2M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.